Skip to main content
AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.930
-0.030 (-1.01%)
At close: Feb 27, 2026, 4:00 PM EST
2.963
+0.033 (1.13%)
After-hours: Feb 27, 2026, 6:28 PM EST

AC Immune Revenue

AC Immune had revenue of 939.00K CHF in the quarter ending September 30, 2025, a decrease of -96.32%. This brings the company's revenue in the last twelve months to 4.37M, down -89.33% year-over-year. In the year 2024, AC Immune had annual revenue of 27.31M with 84.51% growth.

Revenue (ttm)
4.37M CHF
Revenue Growth
-89.33%
P/S Ratio
52.87
Revenue / Employee
25,419 CHF
Employees
172
Market Cap
289.90M USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202427.31M12.51M84.51%
Dec 31, 202314.80M10.87M276.14%
Dec 31, 20223.94M--
Dec 31, 2021---
Dec 31, 202015.43M-95.03M-86.03%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
Cellectis 82.55M
Fennec Pharmaceuticals 38.79M
X4 Pharmaceuticals 33.98M
Opus Genetics 14.63M
Abeona Therapeutics 400.00K
Inhibikase Therapeutics 1.00
Adlai Nortye -1.35M
Revenue Rankings

ACIU News

More News